| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/HH2401.101909 |
| P953 | full work available online at | https://www.ahajournals.org/doi/full/10.1161/hh2401.101909 |
| https://www.ahajournals.org/doi/pdf/10.1161/hh2401.101909 | ||
| P698 | PubMed publication ID | 11739281 |
| P5875 | ResearchGate publication ID | 11617837 |
| P50 | author | Linda J. Metheny-Barlow | Q124850014 |
| P2093 | author name string | J. Yu | |
| H. Pan | |||
| L. Y. Li | |||
| S. Tian | |||
| G. L. Yu | |||
| A. J. Hayes | |||
| L. J. Chew | |||
| L. Metheny-Barlow | |||
| P2860 | cites work | Association of human cyclin E with a periodic G1-S phase protein kinase | Q67505073 |
| Inhibition of angiogenesis and breast cancer xenograft tumor growth by VEGI, a novel cytokine of the TNF superfamily | Q77849637 | ||
| VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo | Q22008595 | ||
| The retinoblastoma protein and cell cycle control | Q27860722 | ||
| Angiogenesis in cancer, vascular, rheumatoid and other disease | Q29547165 | ||
| Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis | Q29547178 | ||
| Mechanisms of angiogenesis | Q29547485 | ||
| G1 events and regulation of cell proliferation | Q29618317 | ||
| Features of apoptotic cells measured by flow cytometry | Q33189237 | ||
| Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle | Q33319961 | ||
| New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. | Q33739301 | ||
| The role of apoptosis in vascular disease | Q33843548 | ||
| TL1, a novel tumor necrosis factor-like cytokine, induces apoptosis in endothelial cells. Involvement of activation of stress protein kinases (stress-activated protein kinase and p38 mitogen-activated protein kinase) and caspase-3-like protease | Q34486473 | ||
| myc function and regulation | Q35671084 | ||
| Bovine brain and pituitary fibroblast growth factors: comparison of their abilities to support the proliferation of human and bovine vascular endothelial cells | Q36208553 | ||
| Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine | Q37348764 | ||
| Diminished Heparin Binding of a Basic Fibroblast Growth Factor Mutant Is Associated with Reduced Receptor Binding, Mitogenesis, Plasminogen Activator Induction, and in vitro Angiogenesis | Q38304429 | ||
| 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO | Q40505449 | ||
| Cdc2 and Cdk2 kinase activated by transforming growth factor-beta1 trigger apoptosis through the phosphorylation of retinoblastoma protein in FaO hepatoma cells | Q40920245 | ||
| Myc and the cell cycle | Q41703353 | ||
| Cyclin a is required for the onset of DNA replication in mammalian fibroblasts | Q44752373 | ||
| Endothelial cell apoptosis in capillary network remodeling | Q54105239 | ||
| Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol | Q58150267 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| endothelium | Q111140 | ||
| cell growth | Q189159 | ||
| P304 | page(s) | 1161-1167 | |
| P577 | publication date | 2001-12-01 | |
| 2001-12-07 | |||
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Modulation of endothelial cell growth arrest and apoptosis by vascular endothelial growth inhibitor | |
| Modulation of Endothelial Cell Growth Arrest and Apoptosis by Vascular Endothelial Growth Inhibitor | |||
| P478 | volume | 89 |
| Q37246949 | A case-control study about the association between vascular endothelial growth inhibitor gene polymorphisms and breast cancer risk in female patients in Northeast China |
| Q37990448 | Advancement in the research on vascular endothelial growth inhibitor (VEGI) |
| Q24803786 | Antiangiogenic gene therapy of cancer: recent developments |
| Q39912239 | Approaches to efficient production of recombinant angiogenesis inhibitor rhVEGI-192 and characterization of its structure and antiangiogenic function |
| Q37720009 | Changes in TL1A levels and associated cytokines during pathogenesis of diabetic retinopathy |
| Q42260610 | Characterization of cis-regulatory elements of the vascular endothelial growth inhibitor gene promoter |
| Q36245717 | Characterization of synovial angiogenesis in osteoarthritis patients and its modulation by chondroitin sulfate |
| Q63976622 | Comparative Transcriptomic Analysis Identifies a Range of Immunologically Related Functional Elaborations of Lymph Node Associated Lymphatic and Blood Endothelial Cells |
| Q58791672 | Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15 |
| Q39419250 | Down-modulation of TNFSF15 in ovarian cancer by VEGF and MCP-1 is a pre-requisite for tumor neovascularization |
| Q39878496 | Effect of sodium butyrate on lung vascular TNFSF15 (TL1A) expression: differential expression patterns in pulmonary artery and microvascular endothelial cells |
| Q36308083 | Effects of endostatin-vascular endothelial growth inhibitor chimeric recombinant adenoviruses on antiangiogenesis |
| Q38803596 | Evaluation of (188)Re-labeled NGR-VEGI protein for radioimaging and radiotherapy in mice bearing human fibrosarcoma HT-1080 xenografts |
| Q34252820 | Functional genetic variants of TNFSF15 and their association with gastric adenocarcinoma: a case-control study |
| Q46428475 | Gene expression profile in colon cancer cells with respect to XIAP expression status. |
| Q42700465 | Gene expression profiling of DMU-212-induced apoptosis and anti-angiogenesis in vascular endothelial cells |
| Q111441835 | Heme Oxygenase-1 at the Nexus of Endothelial Cell Fate Decision Under Oxidative Stress |
| Q46886695 | In vivo NIRF imaging-guided delivery of a novel NGR-VEGI fusion protein for targeting tumor vasculature |
| Q42013131 | Inhibition of corneal neovascularization by vascular endothelia growth inhibitor gene |
| Q57219256 | Inhibition of corneal neovascularization by vascular endothelia growth inhibitor gene |
| Q37202006 | Inhibition of endothelial progenitor cell differentiation by VEGI. |
| Q39076405 | Interferon-γ produced by tumor-infiltrating NK cells and CD4+ T cells downregulates TNFSF15 expression in vascular endothelial cells |
| Q36731993 | Intracellular pH sensors: design principles and functional significance |
| Q36579297 | Involvement of RB gene family in tumor angiogenesis. |
| Q36308777 | Molecule action mechanisms of NM-3 on human gastric cancer SGC-7901 cellsin vivoorin vitro |
| Q42700491 | New insights into the signaling mechanism of the pH-responsive, membrane-integrated transcriptional activator CadC of Escherichia coli |
| Q35208938 | Placental expression of miR-517a/b and miR-517c contributes to trophoblast dysfunction and preeclampsia |
| Q36844365 | Preparation and characterization of a novel chimeric protein VEGI-CTT in Escherichia coli |
| Q91880128 | Return to the Sea, Get Huge, Beat Cancer: An Analysis of Cetacean Genomes Including an Assembly for the Humpback Whale (Megaptera novaeangliae) |
| Q36445840 | STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier |
| Q36284920 | TNFSF15 Modulates Neovascularization and Inflammation |
| Q37117794 | TNFSF15 inhibits vasculogenesis by regulating relative levels of membrane-bound and soluble isoforms of VEGF receptor 1 |
| Q61797274 | TNFSF15 promoter polymorphisms increase the susceptibility to small cell lung cancer: a case-control study |
| Q37688387 | TNFSF15 suppresses VEGF production in endothelial cells by stimulating miR-29b expression via activation of JNK-GATA3 signals |
| Q41233155 | Targeting of apoptotic pathways by SMAC or BH3 mimetics distinctly sensitizes paclitaxel-resistant triple negative breast cancer cells. |
| Q40814371 | Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells |
| Q34195262 | Two functionally distinct isoforms of TL1A (TNFSF15) generated by differential ectodomain shedding |
| Q36737050 | Understanding endothelial cell apoptosis: what can the transcriptome, glycome and proteome reveal? |
| Q43240879 | VEGI-armed oncolytic adenovirus inhibits tumor neovascularization and directly induces mitochondria-mediated cancer cell apoptosis |
| Q41017078 | Vascular endothelial growth factor suppresses TNFSF15 production in endothelial cells by stimulating miR-31 and miR-20a expression via activation of Akt and Erk signals |
| Q28300434 | Vascular endothelial growth inhibitor (VEGI), an endogenous negative regulator of angiogenesis |
| Q34587733 | Vascular endothelial growth inhibitor (VEGI; TNFSF15) inhibits bone marrow-derived endothelial progenitor cell incorporation into Lewis lung carcinoma tumors |
| Q34988841 | c-Myc is essential to prevent endothelial pro-inflammatory senescent phenotype |
Search more.